GBM is not listed in the 90 LL indications on thi
Post# of 150216
(Total Views: 488)
Posted On: 05/25/2022 10:04:43 PM
Quote:
[1] GBM is not listed in the 90 LL indications on this board
I never listed individual cancers.
Quote:
CCR5 is highly expressed in glioblastoma and is associated with poor prognosis of patients. CCL5/CCR5 is suggested to be an excellent new target for glioblastoma therapy.
Clinical trials have recently opened targeting CCR5 using a humanized monoclonal antibody (leronlimab) for metastatic triple negative breast cancer (TNBC)
Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼